Skip to content

Controlled study to investigate the efficacy of the insect bite healer BR 60 against pruritus and swelling after mosquito bites (MüPruritus)

Controlled study to investigate the efficacy of the insect bite healer BR 60 against pruritus and swelling after mosquito bites (MüPruritus) - MüPruritus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033004
Enrollment
20
Registered
2023-11-08
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T13.03

Interventions

Group 1: One sting per patient is treated thermally with the BR 60 insect sting healer. Group 2: One sting per patient remains untreated.

Sponsors

Institut Kurscheid
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Consent to the study - >18 years - Knowledge of own reaction to insect bites - Willingness to be bitten twice by the two mosquito strains laboratory strains

Exclusion criteria

Exclusion criteria: - Allergies to insect bites - Acute skin diseases in the region - Acute illnesses (especially with a tendency to thromboembolic diseases and malignant neoplasms) - Chronic pain conditions that have not been clarified, regardless of the body region - Diabetes - Sensitivity disorder with reduced pain sensation (e.g. metabolic disorder)

Design outcomes

Primary

MeasureTime frame
Difference in pruritus severity between treated and untreated prick on a 10-point VAS score over 1 hour (AUC)

Secondary

MeasureTime frame
Difference in pruritus severity between treated and untreated bites on a 10-point VAS score over 1 hour (AUC) Yellow fever mosquito (Aedes aegypti) and southern house mosquito (Culex quinquefasciatus) (10 patients) - Difference in pruritus severity between treated and untreated bites on a 10-point VAS score at the time points 2, 7, 11, 15, 40, 60 minutes (AUC) for all mosquitoes and each individual mosquito - Difference in swelling between treated and untreated bite on a 10-point VAS score over 1 hour (AUC) - Difference in redness between treated and untreated bite on a 10 point VAS score over 1 hour (AUC)

Countries

Germany

Contacts

Public ContactSergej Sperling

Biogents AG

sergej.sperling@biogents.com+49 941 945 833 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026